Prevalência de fatores de risco cardiovascular e outras comorbilidades em doentes com hipertensão arterial assistidos nos Cuidados de Saúde Primários: estudo Precise

Tu, 2010, Reducing the global burden of stroke: INTERSTROKE, Lancet., 376, 74, 10.1016/S0140-6736(10)60975-0 Fuchs, 2018, Risks of high blood pressure and goals for treatment, In: Fuch FD. Essentials of Hypertension. The 120/80 paradigm. Switzerland: Springer International Publishing AG, 1 Lewington, 2002, Age‐specific relevance of usual blood pressure to vascular mortality: a meta‐analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 NCD Risk Factor Collaboration (NCD‐RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population‐based measurement studies with 19·1 million participants. Lancet. 2017; 389(10064): 37‐55. doi: 10.1016/S0140‐6736(16)31919‐5. Polonia, 2014, Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study, J Hypertens., 32, 1211, 10.1097/HJH.0000000000000162 Macedo, 2005, Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study, J Hypertens., 23, 1661, 10.1097/01.hjh.0000179908.51187.de GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990‐2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1659‐1724. doi: 10.1016/S0140‐6736(16)31679‐8. Rocha, 2017, The global burden of disease: an information resource for policy‐making and evaluation of health interventions, Rev Port Cardiol., 36, 283, 10.1016/j.repc.2017.02.007 Direção‐Geral da Saúde. Direção de Serviços de Informação e Análise. A Saúde dos Portugueses 2016. Lisboa: DGS, 2017. Poulter, 1996, Concomitant risk factors in hypertensives: a survey of risk factors for cardiovascular disease amongst hypertensives in English general practices, Blood Press., 4, 209, 10.3109/08037059609079673 Vyssoulis, 2012, Cardiovascular risk factor(s) prevalence in Greek hypertensives, Effect of gender and age. J Hum Hypertens., 26, 443, 10.1038/jhh.2011.55 Kannel, 2000, Risk stratification in hypertension: new insights from the Framingham Study, Am J Hypertens., 13, 3S, 10.1016/S0895-7061(99)00252-6 Lloyd-Jones, 1999, Cross‐classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study, Arch Intern Med., 159, 2206, 10.1001/archinte.159.18.2206 Franklin, 2013, Hypertension and cardiovascular disease: contributions of the Framingham Heart Study, Glob Heart., 8, 49, 10.1016/j.gheart.2012.12.004 Piepoli, 2016, Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J., 37, 2315 D’Agostino, 2008, General cardiovascular risk profile for use in primary care: the Framingham Heart Study, Circulation., 117, 743, 10.1161/CIRCULATIONAHA.107.699579 2018, Classification and diagnosis of diabetes: standards of medical care in diabetes‐2018, Diabetes Care., 41, S13 Sever, 2001, Rationale, design, methods and baseline demography of participants of the Anglo‐Scandinavian Cardiac Outcomes Trial ASCOT investigators, J Hypertens., 19, 1139, 10.1097/00004872-200106000-00020 Mounier-Vehier, 2002, J Arch Mal Coeur Vaiss., 95, 667 Laucevičius, 2014, Prevalence of high‐risk profile in middle‐aged subjects with arterial hypertension: a nationwide survey, Blood Press., 23, 281, 10.3109/08037051.2014.883187 Tocci, 2014, Clinical management of patients with hypertension and high cardiovascular risk: main results of an Italian survey on blood pressure control, High Blood Press Cardiovasc Prev., 21, 107, 10.1007/s40292-013-0028-x Noh, 2016, Prevalence of comorbidity among people with hypertension: the Korea National Health and Nutrition Examination Survey 2007‐2013, Korean Circ J., 46, 672, 10.4070/kcj.2016.46.5.672 Lonn, 2016, Novel approaches in primary cardiovascular disease prevention: The HOPE‐3 trial rationale, design, and participants’ baseline characteristics, Can J Cardiol., 32, 311, 10.1016/j.cjca.2015.07.001 Wang, 2017, Prevalence and risk factors of comorbidities among hypertensive patients in China, J Med Sci., 14, 201 Polónia, 2010, Estratificação do risco cardiovascular global de doentes hipertensos seguidos em Portugal nos cuidados saúde primários ou hospitalares segundo as orientações ESH/ESC 2007, Rev Port Cardiol., 29, 1685 Atlas Writing Group, 2018, European Society of Cardiology: Cardiovascular Disease Statistics 2017, Eur Heart J., 39, 508, 10.1093/eurheartj/ehx628 Macedo, 2015, A hipertensão arterial nos Cuidados de Saúde Primários, em Portugal: contributo para o conhecimento epidemiológico da população em 2013, Revista Factores de Risco., 36, 47 Instituto Nacional de Estatística. Inquérito Nacional de Saúde 2014. Lisboa: INE, I.P., 2016. Rodrigues, 2017, Prevalência de hipertensão arterial em Portugal: resultados do Primeiro Inquérito Nacional com Exame Físico (INSEF 2015), Observações_Boletim Epidemiológico., 9, 12 Hobbs, 2010, Barriers to cardiovascular disease risk scoring and primary prevention in Europe, QJM., 103, 727, 10.1093/qjmed/hcq122 Redon, 2016, Global cardiovascular risk assessment: strengths and limitations, High Blood Press Cardiovasc Prev., 23, 87, 10.1007/s40292-016-0139-2 Mancia, 2013, et al., 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), J Hypertens., 31, 1281, 10.1097/01.hjh.0000431740.32696.cc Whelton, 2017, ACC/AHA/AAPA/ABC/ACPM/AGS /APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults, J Am Coll Cardiol. 2017. Nerenberg, 2018, Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children, Can J Cardiol., 10.1016/j.cjca.2018.02.022 de la Sierra, 2012, Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs, J Hypertens., 30, 1211, 10.1097/HJH.0b013e328353634e Cooney, 2009, Polypharmacy in the elderly: focus on drug interactions and adherence in hypertension, Clin Geriatr Med, 25, 221, 10.1016/j.cger.2009.01.005 Egan, 2013, Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988‐2010, Circulation., 128, 29, 10.1161/CIRCULATIONAHA.112.000500 Morgado, 2011, Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice, J Cardiovasc Dis Res, 2, 44, 10.4103/0975-3583.78596 Frankel, 2018, Integrated Care for Complex Patients. A Narrative Medicine Approach, Switzerland: Springer International Publishing AG